title: [Target gene sequence capture and next generation sequencing technology to diagnose four children with Alagille syndrome].
abstract: OBJECTIVE
  To make genetic diagnosis of Alagille syndrome (ALGS) patients using target gene sequence capture and next generation sequencing technology.
  
  
  METHODS
  Target gene sequence capture and next generation sequencing were used to detect ALGS gene of 4 patients. They were hospitalized at the Affiliated Hospital, Capital Institute of Pediatrics between January 2014 and December 2015, referred to clinical diagnosis of ALGS typical and atypical respectively in 2 cases. Blood samples were collected from patients and their parents and genomic DNA was extracted from lymphocytes. Target gene sequence capture and next generation sequencing was detected. Sanger sequencing was used to confirm the results of the patients and their parents.
  
  
  RESULTS
  Cholestasis, heart defects, inverted triangular face and butterfly vertebrae were presented as main clinical features in 4 male patients. The first hospital visiting ages ranged from 3 months and 14 days to 3 years and 1 month. The age of onset ranged from 3 days to 42 days (median 23 days). According to the clinical diagnostic criteria of ALGS, patient 1 and patient 2 were considered as typical ALGS. The other 2 patients were considered as atypical ALGS. Four Jagged 1(JAG1) pathogenic mutations were detected. Three different missense mutations were detected in patient 1 to patient 3 with ALGS(c.839C>T(p.W280X), c. 703G>A(p.R235X), c. 1720C>T(p.V574M)). The JAG1 mutation of patient 3 was first reported. Patient 4 had one novel insertion mutation (c.1779_1780insA(p.Ile594AsnfsTer23)). Parental analysis verified that the JAG1 missense mutation of 3 patients were de novo. The results of sanger sequencing was consistent with the results of the next generation sequencing.
  
  
  CONCLUSIONS
  Target gene sequence capture combined with next generation sequencing can detect two pathogenic genes in ALGS and test genes of other related diseases in infantile cholestatic diseases simultaneously and presents a high throughput, high efficiency and low cost. It may provide molecular diagnosis and treatment for clinicians with good clinical application prospects.
authors.affiliation: Department of Gastroenterology, the Affiliated Hospital, Capital Institute of Pediatrics, Beijing 100020, China.
authors.forename: M L
authors.initials: ML
authors.lastname: Gao
authors.forename: X M
authors.initials: XM
authors.lastname: Zhong
authors.forename: X
authors.initials: X
authors.lastname: Ma
authors.forename: H J
authors.initials: HJ
authors.lastname: Ning
authors.forename: D
authors.initials: D
authors.lastname: Zhu
authors.forename: J Z
authors.initials: JZ
authors.lastname: Zou
mesh_terms: D016738:Alagille Syndrome / Q000175:diagnosis* / Q000235:genetics*; D002675:Child, Preschool; D004252:DNA Mutational Analysis; D059014:High-Throughput Nucleotide Sequencing; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D000072100:Jagged-1 Protein / Q000235:genetics; D008297:Male; D020125:Mutation, Missense
chemical_list: C000606273:JAG1 protein, human; D000072100:Jagged-1 Protein